Brandywine Global Investment Management LLC Has $5.33 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Brandywine Global Investment Management LLC reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 7.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 77,046 shares of the company's stock after selling 5,960 shares during the quarter. Brandywine Global Investment Management LLC owned about 0.06% of Henry Schein worth $5,332,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of HSIC. Physician Wealth Advisors Inc. bought a new position in shares of Henry Schein in the 4th quarter worth $138,000. California Public Employees Retirement System boosted its holdings in Henry Schein by 3.2% during the fourth quarter. California Public Employees Retirement System now owns 587,915 shares of the company's stock worth $40,684,000 after buying an additional 18,143 shares during the last quarter. Allstate Corp bought a new position in Henry Schein during the fourth quarter worth about $278,000. Brown Brothers Harriman & Co. grew its position in shares of Henry Schein by 6.4% during the 4th quarter. Brown Brothers Harriman & Co. now owns 11,184 shares of the company's stock worth $774,000 after buying an additional 671 shares during the period. Finally, Pictet Asset Management Holding SA increased its stake in shares of Henry Schein by 8.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 77,848 shares of the company's stock valued at $5,387,000 after acquiring an additional 6,338 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on HSIC shares. UBS Group decreased their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Barrington Research restated an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America upgraded Henry Schein from an "underperform" rating to a "buy" rating and lifted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Finally, Wells Fargo & Company initiated coverage on Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $81.10.

Insider Activity at Henry Schein

In related news, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. This trade represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Henry Schein Stock Down 1.7 %

NASDAQ:HSIC traded down $1.12 during trading hours on Friday, reaching $65.47. 2,362,489 shares of the stock were exchanged, compared to its average volume of 1,585,938. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a twelve month low of $63.00 and a twelve month high of $82.49. The stock has a market cap of $8.13 billion, a PE ratio of 26.94, a PEG ratio of 2.13 and a beta of 0.84. The firm has a 50 day moving average of $73.96 and a 200 day moving average of $72.58.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the previous year, the company posted $0.66 EPS. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.